Organization
University Hospital Hamburg Eppendorf
2 abstracts
Abstract
CLDN6 CAR-T cell therapy of relapsed/refractory solid tumors ± a CLDN6-encoding mRNA vaccine: Dose escalation data from the BNT211-01 phase 1 trial using an automated product.Org: Friedrich-Alexander University Erlangen-Nuremberg, Netherlands Cancer Institute, Hannover Medical School, University Hospital Hamburg Eppendorf, University Medical Center Mainz,
Abstract
Platinum-based chemotherapy in patients with castration-resistant prostate cancer and hepatic metastases.Org: Martini-Clinic, Prostate Cancer Center Hamburg and Department of Oncology, University Hospital Hamburg Eppendorf, Department of Urology, Jinling Hospital, Clinical School of Medical College, Nanjing University, Nanjing, China, Rechts der Isar Medical Center,